<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Front. Biomater. Sci.</journal-id>
<journal-title>Frontiers in Biomaterials Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Front. Biomater. Sci.</abbrev-journal-title>
<issn pub-type="epub">2813-3749</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1215427</article-id>
<article-id pub-id-type="doi">10.3389/fbiom.2023.1215427</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biomaterials Science</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Women in Biomaterials Science 2022</article-title>
<alt-title alt-title-type="left-running-head">Zustiak et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbiom.2023.1215427">10.3389/fbiom.2023.1215427</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zustiak</surname>
<given-names>Silviya P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/180090/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Oyen</surname>
<given-names>Michelle L.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/921926/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Scielzo</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/111204/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biomedical Engineering</institution>, <institution>Saint Louis University</institution>, <addr-line>St Louis</addr-line>, <addr-line>MO</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Deparment of Biomedical Engineering</institution>, <institution>Washington University</institution>, <addr-line>St Louis</addr-line>, <addr-line>MO</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Malignant B Cells Biology and 3D Modelling Unit</institution>, <institution>Division of Experimental Oncology</institution>, <institution>IRCCS-Hospital San Raffaele</institution>, <addr-line>Milan</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/712466/overview">Silvia Fare</ext-link>, Polytechnic University of Milan, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Silviya P. Zustiak, <email>silviya.zustiak@slu.edu</email>; Michelle L. Oyen, <email>oyen@wustl.edu</email>; Cristina Scielzo, <email>scielzo.cristina@hsr.it</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>2</volume>
<elocation-id>1215427</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zustiak, Oyen and Scielzo.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zustiak, Oyen and Scielzo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Front. Biomater. Sci." xlink:href="https://www.frontiersin.org/researchtopic/34811" ext-link-type="uri">Editorial on the Research Topic <article-title>Women in Biomaterials Science 2022</article-title>
</related-article>
<kwd-group>
<kwd>drug delivery</kwd>
<kwd>nanoparticles</kwd>
<kwd>microspheres</kwd>
<kwd>bioprinting</kwd>
<kwd>electrospinning</kwd>
<kwd>polymers</kwd>
<kwd>metals</kwd>
<kwd>ceramics</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Bioinspired and Complex Materials</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>We are excited to present the inaugural Research Topic &#x201c;Women in Biomaterials Science.&#x201d; This Research Topic aims to highlight the excellent work performed by female-identifying scientists in the field of biomaterials and to encourage more women to pursue careers in the field. Each paper in the Research Topic has a female corresponding author, two of the lead authors are women and a total of seventeen female scientists are represented as co-authors for all manuscripts. The topics covered in this Research Topic are diverse - from electrospun and 3D printed materials, to micro- and nanoparticles and from drug delivery devices and cell scaffolds to biomaterials for agricultural applications (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic representation of the biomaterials science topics covered in the Research Topic of Women in Biomaterials Science 2022.</p>
</caption>
<graphic xlink:href="fbiom-02-1215427-g001.tif"/>
</fig>
<p>A paper from the laboratory of Dr. Candice Majewski from the Department of Mechanical Engineering at The University of Sheffield in Sheffield, United Kingdom, focused on developing antibacterial surfaces to control the spread of infectious disease (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.929006/full">Wingham et al.</ext-link>). Specifically, the authors used a Laser Sintering Additive Manufacturing process to produce antimicrobial microcomposites by incorporating silver phosphate glass additives in parts made of polyamide 12, a common additive manufacturing polymer used in polymer powder bed fusion processes. The antimicrobial efficacy was tuned by controlling dissolution rates and silver content, and the microcomposites showed efficacy, both antifouling and bactericidal, against Gram-positive and Gram-negative bacteria (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.929006/full">Wingham et al.</ext-link>).</p>
<p>Several other manuscripts in this Research Topic covered the development of various biomaterial systems for drug delivery applications (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.1003172/full">Chandrasiri et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.928537/full">Hernandez et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2023.1157554/full">Dharmesh et al.</ext-link>). In a paper from the laboratory of Dr. Silviya P. Zustiak from the Department of Biomedical Engineering at Saint Louis University in Saint Louis, MO, the team developed nanocomposite hydrogel microspheres for sustained release of small molecules (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2023.1157554/full">Dharmesh et al.</ext-link>). Specifically, the authors used a simple and scalable aqueous phase separation method to fabricate injectable polyethylene glycol microspheres impregnated with nanosilicates. Nanosilicate concentration was varied to control the release of multiple small molecules, such as doxorubicin, acridine orange and brilliant blue, over days and weeks, while minimizing burst release (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2023.1157554/full">Dharmesh et al.</ext-link>). In another article in this Research Topic, Dr. Kim A Woodrow and her team from the Department of Bioengineering at the University of Washington in Seattle, WA, used electrospinning to produce drug-eluting fibrous biomaterials (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.928537/full">Hernandez et al.</ext-link>). In particular, the authors optimized a scalable, high-productivity free-surface electrospinning process to produce materials of uniform area density (&#x3c;10% coefficient of variance) and high drug loading, and showed the simultaneous release of multiple drugs (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.928537/full">Hernandez et al.</ext-link>). Finally, in a paper from the laboratory of Danielle S. W. Benoit from the Department of Biomedical Engineering at the University of Rochester in Rochester, NY, the authors describe peptide functionalization of polymeric nanoparticles, again focusing on system reproducibility and tunability for efficient drug delivery (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.1003172/full">Chandrasiri et al.</ext-link>). Specifically, the authors showed undesired intra- and intermolecular crosslinking for multi-amine peptides, where primary amines are commonly used for peptide conjugation, or carbodiimide coupling reagents. In contrast, peptide-polymer conjugates with reproducible dispersity and molecular weight were achieved by using selectively protected peptides as well as using anhydride ring-opening nucleophilic addition elimination for cyclic anhydride-containing polymers (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.1003172/full">Chandrasiri et al.</ext-link>).</p>
<p>A bioink for the 3D bioprinting of lymphoid cells is described in collaborative work by Dr. Cristina Scielzo from the Division of Experimental Oncology at IRCCS Ospedale San Raffaele in Milano, Italy and Dr. Silvia Fare from the Department of Chemistry, Materials and Chemical Engineering at Politecnico di Milano in Milano, Italy (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2023.1081065/full">Ribezzi et al.</ext-link>). The authors used different blend formulations of alginate, gelatin, and methylcellulose and demonstrated good shape fidelity and printing accuracy. The bioink was laden with lymphoid cells isolated from patients with Chronic Lymphocytic Leukemia and cultured for up to 3 weeks upon 3D bioprinting, showing good scaffold stability and mechanical properties similar to those of lymphoid tissues (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2023.1081065/full">Ribezzi et al.</ext-link>).</p>
<p>Lastly, a review paper from the laboratory of Dr. Jessica O. winter from the Department of Chemical and Biomolecular Engineering at The Ohio State University in Columbus, OH, explores the idea of translating knowledge from the biomedical controlled release field, such as release devices, &#x2018;smart&#x2019; release designs for on-demand release in response to environmental cues, or theranostic systems that combine sensing and release for real-time monitoring of interventions, to agriculture applications, such as soil ecology, microbiology, horticulture, and crop sciences (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.1011877/full">Lee et al.</ext-link>). The goal of such controlled release systems would be to address the global challenge of sustainable food production. Examples include improving targeting of agrochemicals such as nutrients and pesticides to reduce waste and cost while enabling environmental sustainability (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbiom.2022.1011877/full">Lee et al.</ext-link>).</p>
<p>The papers in this Research Topic represent a small portion of the female investigators working in the biomaterials field. However, they are a good illustration of the diversity of ideas and approaches, the breadth and depth of the work, and the objective to address global challenges such as food insecurity, infectious disease and cancer.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>The author(s) S.P.Z, M.L.O and C.S. declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>